NCT06960213View on ClinicalTrials.gov

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

PHASE3RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 28, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Hereditary Angioedema
Interventions
DRUG

ADX-324

siRNA duplex oligonucleotide

DRUG

Placebo

saline

Trial Locations (1)

72205

RECRUITING

Acuro Research, Inc., Little Rock

Sponsors
All Listed Sponsors
lead

ADARx Pharmaceuticals, Inc.

INDUSTRY